Efficacy of vitamin E and N-acetylcysteine in the prevention of Contrast induced kidney injury in patients with chronic kidney disease: A double blind, randomized controlled trial

Wiener Klinische Wochenschrift

Volumn 124, Issue 9-10, 2012, Pages 312-319

  Kitzler, Thomas M ^c   Jaberi, Aala ^d   Sendlhofer, Gerald ^e   Rehak, Peter ^f   Binder, Christian ^g   Petnehazy, Eva ^g   Stacher, Rudolf ^g   Kotanko, Peter ^a,b,g  

^a RENAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY HOSPITAL GRAZ   (Austria)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Chronic kidney disease; Computer assisted tomography; Contrast induced acute kidney injury; N acetylcysteine; Randomized controlled trial; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; CONTRAST MEDIUM; CREATININE; IOPROMIDE; SODIUM CHLORIDE;

AGED; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STANDARD; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; AGED; CONTRAST MEDIA; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; IOHEXOL; KIDNEY FAILURE, CHRONIC; MALE; TREATMENT OUTCOME; VITAMIN E;

EID: 84863725201     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-012-0169-2     Document Type: Article

References (32)

1. McCullough PA, Sandberg KR. Epidemiology of contrastinduced nephropathy. Rev Cardiovasc Med. 2003;4(Suppl 5):S3-9.
2. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:S11-5.
3. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-28. (Pubitemid 351471786)
4. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol. 2008;3:10-18.
5. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68:14-22. (Pubitemid 43181360)
6. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin. 2005;21:261-80. (Pubitemid 40386754)
7. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med. 1995;332:647-55.
8. Arakawa K, Suzuki H, Naitoh M, Matsumoto A, Hayashi K, Matsuda H, et al. Role of adenosine in the renal responses to contrast medium. Kidney Int. 1996;49:1199-1206. (Pubitemid 26167274)
9. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C. Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol. 1983;18:160-6. (Pubitemid 13111339)
10. Liss P, Nygren A, Olsson U, Ulfendahl HR, Erikson U. Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int. 1996;49:1268-75. (Pubitemid 26167278)
11. Nygren A, Ulfendahl HR, Hansell P, Erikson U. Effects of intravenous contrast media on cortical and medullary blood flow in the rat kidney. Invest Radiol. 1988;23:753-61.
12. Bakris GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int. 1999;56:206-10. (Pubitemid 29300536)
13. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284-91. (Pubitemid 37430561)
14. Juncos R, Garvin JL. Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb. Am J Physiol Renal Physiol. 2005;288:F982-7. (Pubitemid 40569764)
15. Wellman TL, Jenkins J, Penar PL, Tranmer B, Zahr R, Lounsbury KM. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries. FASEB J. 2004;18:379-81.
16. Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant. 2004;19:1803-7. (Pubitemid 38961391)
17. Sandhu C, Newman DJ, Morgan R, Belli AM, Oliveira D. The role of oxygen free radicals in contrast induced nephrotoxicity. Acad Radiol. 2002;9(Suppl 2):S436-7. (Pubitemid 34857746)
18. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia. 2003;46:1153-60. (Pubitemid 37041246)
19. Abd-El-Fattah AA, El-Sawalhi MM, Rashed ER, El-Ghazaly MA. Possible role of vitamin E, coenzyme Q10 and rutin in protection against cerebral ischemia/reperfusion injury in irradiated rats. Int J Radiat Biol. 2010;86:1070-8.
20. Abu-Amara M, Gurusamy K, Hori S, Glantzounis G, Fuller B, Davidson BR. Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB (Oxford). 2010;12:4-14.
21. Pflueger A, Abramowitz D, Calvin AD. Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus. Med Sci Monit. 2009;15:RA125-36.
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70. (Pubitemid 29135798)
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12.
24. Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-4. (Pubitemid 30489215)
25. Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. Trials. 2009;10:45.
26. Calvin AD, Misra S, Pflueger A. Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol. 2010;6:679-88.
27. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773-82. (Pubitemid 43974195)
28. Rigotti A. Absorption, transport, and tissue delivery of vitamin E. Mol Aspects Med. 2007;28:423-36. (Pubitemid 47625528)
29. Nakamura T, Aoyama Y, Fujita T, Katsui G. Studies on tocopherol derivatives: V. Intestinal absorption of several d, 1-3, 4-3H2-alpha-tocopheryl esters in the rat. Lipids. 1975;10:627-33.
30. Traber MG, Goldberg I, Davidson E, Lagmay N, Kayden HJ. Vitamin E uptake by human intestinal cells during lipolysis in vitro. Gastroenterology. 1990;98:96-103. (Pubitemid 20017789)
31. Tasanarong A, Piyayotai D, Thitiarchakul S. Protection of radiocontrast induced nephropathy by vitamin E (alpha tocopherol): a randomized controlled pilot study. J Med Assoc Thai. 2009;92:1273-81.
32. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211-7. (Pubitemid 46594764)